KILIÇKAP, M. Et Al. 2024. GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis. ANGIOLOGY , vol.75, no.9 , 820-830.

KILIÇKAP, M., KOZLUCA, V., TAN KÜRKLÜ, T. S., & AKBULUT KOYUNCU, İ. M., (2024). GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis. ANGIOLOGY , vol.75, no.9, 820-830.

KILIÇKAP, MUSTAFA Et Al. "GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis," ANGIOLOGY , vol.75, no.9, 820-830, 2024

KILIÇKAP, MUSTAFA Et Al. "GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis." ANGIOLOGY , vol.75, no.9, pp.820-830, 2024

KILIÇKAP, M. Et Al. (2024) . "GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis." ANGIOLOGY , vol.75, no.9, pp.820-830.

@article{article, author={MUSTAFA KILIÇKAP Et Al. }, title={GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis}, journal={ANGIOLOGY}, year=2024, pages={820-830} }